AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023 Market News
LUPKYNIS® Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone Life Science Investing
COMPASS Pathways' Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer Psychedelics Investing
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease Pharmaceutical Investing
Komo Plant Based Foods Inc. Announces Expanded Distribution Through Koyo Foods Inc. Biotech Investing
